Home / Companies / News / Pfizer, BioNTech to supply 120 mn doses of coronavirus vaccine to Japan

Pfizer, BioNTech to supply 120 mn doses of coronavirus vaccine to Japan

BioNTech and Pfizer on Monday began a large, late-stage trial of their vaccine candidate to demonstrate its efficacy

covid, coronavirus, vaccine, drug, pharma

Premium

Assuming clinical success of the vaccines, Pfizer and BioNtech said they are on track to seek regulatory review for the vaccine as early as October.

Reuters

2 min read Last Updated : Jul 31 2020 | 5:47 PM IST

Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.

The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.

The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 price tag for what is likely to be a two-dose treatment course.

ALSO READ: Coronavirus LIVE:

Topics : Coronavirus Pfizer Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in